Affect of early life oxygen exposure on proper lung development and response to respiratory viral infections

Frontiers in Medicine

Volumn 2, Issue AUG, 2015, Pages

  Domm, William ^a   Misra, Ravi S ^a   O'Reilly, Michael A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Hyperoxia; Influenza A virus; Innate immunity; Lung development; Prematurity

Indexed keywords

EID: 84983747824     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2015.00055     Document Type: Review

References (173)

1. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet (1989) 2:577-80. doi:10.1016/S0140-6736(89)90710-1
2. Plopper CG, Smiley-Jewell SM, Miller LA, Fanucchi MV, Evans MJ, Buckpitt AR, et al. Asthma/allergic airways disease: does postnatal exposure to environmental toxicants promote airway pathobiology? Toxicol Pathol (2007) 35:97-110. doi:10.1080/01926230601132030
3. Pinkerton KE, Joad JP. The mammalian respiratory system and critical windows of exposure for children's health. Environ Health Perspect (2000) 108(Suppl 3):457-62. doi:10.1289/ehp.00108s3457
4. Kajekar R. Environmental factors and developmental outcomes in the lung. Pharmacol Ther (2007) 114:129-45. doi:10.1016/j.pharmthera.2007.01.011
5. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr (1997) 66:460S-3S
6. Singh V. The burden of pneumonia in children: an Asian perspective. Paediatr Respir Rev (2005) 6:88.93. doi:10.1016/j.prrv.2005.03.002
7. Le Souef PN. Adverse effects of maternal smoking during pregnancy on innate immunity in infants. Eur Respir J (2006) 28:675-7. doi:10.1183/09031936.06.00101206
8. Lafeber HN, Westerbeek EA, Van Den Berg A, Fetter WP, Van Elburg RM. Nutritional factors influencing infections in preterm infants. J Nutr (2008) 138:1813S-1817S
9. Springer KW, Sheridan J, Kuo D, Carnes M. The long-term health outcomes of childhood abuse. An overview and a call to action. J Gen Intern Med (2003) 18:864-70. doi:10.1046/j.1525-1497.2003.20918.x
10. Maeda Y, Dave V, Whitsett JA. Transcriptional control of lung morphogenesis. Physiol Rev (2007) 87:219-44. doi:10.1152/physrev.00028.2006
11. Minoo P. Transcriptional regulation of lung development: emergence of specificity. Respir Res (2000) 1:109-15. doi:10.1186/rr20
12. Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell (2010) 18:8-23. doi:10.1016/j.devcel.2009.12.010
13. Herriges M, Morrisey EE. Lung development: orchestrating the generation and regeneration of a complex organ. Development (2014) 141:502-13. doi:10.1242/dev.098186
14. Kho AT, Bhattacharya S, Mecham BH, Hong J, Kohane IS, Mariani TJ. Expression profiles of the mouse lung identify a molecular signature of time-to-birth. Am J Respir Cell Mol Biol (2009) 40:47-57. doi:10.1165/rcmb.2008-0048OC
15. Xu Y, Wang Y, Besnard V, Ikegami M, Wert SE, Heffner C, et al. Transcriptional programs controlling perinatal lung maturation. PLoS One (2012) 7:e37046. doi:10.1371/journal.pone.0037046
16. Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax (2001) 56:317-23. doi:10.1136/thorax.56.4.317
17. Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol (2006) 30:171-8. doi:10.1053/j.semperi.2006.05.003
18. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics (2005) 116:1353-60. doi:10.1542/peds.2005-0249
19. Merritt TA, Deming DD, Boynton BR. The 'new' bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med (2009) 14:345-57. doi:10.1016/j.siny.2009.08.009
20. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics (2006) 118:108-13. doi:10.1542/peds.2005-2522
21. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J (2003) 22:S33-7. doi:10.1097/01.inf.0000053883.08663.e5
22. Doyle LW, Faber B, Callanan C, Morley R. Blood pressure in late adolescence and very low birth weight. Pediatrics (2003) 111:252-7. doi:10.1542/peds.111.2.252
23. Roberts G, Anderson PJ, Doyle LW. Neurosensory disabilities at school age in geographic cohorts of extremely low birth weight children born between the 1970s and the 1990s. J Pediatr (2009) 154(829-34):e1. doi:10.1016/j.jpeds.2008.12.036
24. Bream EN, Leppellere CR, Cooper ME, Dagle JM, Merrill DC, Christensen K, et al. Candidate gene linkage approach to identify DNA variants that predispose to preterm birth. Pediatr Res (2013) 73:135-41. doi:10.1038/pr.2012.166
25. Ambalavanan N, Cotten CM, Page GP, Carlo WA, Murray JC, Bhattacharya S, et al. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr (2015) 166(531-537):e13. doi:10.1016/j.jpeds.2014.09.052
26. Wang H, St Julien KR, Stevenson DK, Hoffmann TJ, Witte JS, Lazzeroni LC, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics (2013) 132:290-7. doi:10.1542/peds.2013-0533
27. Cruickshank MN, Oshlack A, Theda C, Davis PG, Martino D, Sheehan P, et al. Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy. Genome Med (2013) 5:96. doi:10.1186/gm500
28. Collard KJ, Godeck S, Holley JE, Quinn MW. Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal Ed (2004) 89:F412-6. doi:10.1136/adc.2002.016717
29. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med (2010) 15:191-5. doi:10.1016/j.siny.2010.04.001
30. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res (1999) 46:641-3. doi:10.1203/00006450-199912000-00007
31. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W, et al. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics (2003) 111:469-76. doi:10.1542/peds.111.3.469
32. Buczynski BW, Yee M, Martin KC, Lawrence BP, O'Reilly MA. Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways. Am J Physiol Lung Cell Mol Physiol (2013) 305:L282-90. doi:10.1152/ajplung.00112.2013
33. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med (2005) 172:745-9. doi:10.1164/rccm.200501-146OC
34. Auten RL, O'Reilly MA, Oury TD, Nozik-Grayck E, Whorton MH. Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol (2006) 290:L32-40. doi:10.1152/ajplung.00133.2005
35. Buczynski BW, Maduekwe ET, O'Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol (2013) 37:69-78. doi:10.1053/j.semperi.2013.01.002
36. Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol (2014) 307:L936-47. doi:10.1152/ajplung.00159.2014
37. O'Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol (2014) 307:L948-58. doi:10.1152/ajplung.00160.2014
38. D'Angio CT, Ryan RM. Animal models of bronchopulmonary dysplasia. The preterm and term rabbit models. Am J Physiol Lung Cell Mol Physiol (2014) 307:L959-69. doi:10.1152/ajplung.00228.2014
39. Yoder BA, Coalson JJ. Animal models of bronchopulmonary dysplasia. The preterm baboon models. Am J Physiol Lung Cell Mol Physiol (2014) 307:L970-7. doi:10.1152/ajplung.00171.2014
40. Hilgendorff A, O'Reilly MA. Bronchopulmonary dysplasia early changes leading to long-term consequences. Front Med (2015) 2:2. doi:10.3389/fmed.2015.00002
41. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev (2000) 92:55-81. doi:10.1016/S0925-4773(99)00325-1
42. Hilfer SR. Morphogenesis of the lung: control of embryonic and fetal branching. Annu Rev Physiol (1996) 58:93-113. doi:10.1146/annurev.ph.58.030196.000521
43. Mendelson CR. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol (2000) 62:875-915. doi:10.1146/annurev.physiol.62.1.875
44. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature (2008) 453:745-50. doi:10.1038/nature07005
45. Bourbon JR, Boucherat O, Boczkowski J, Crestani B, Delacourt C. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends Mol Med (2009) 15:169-79. doi:10.1016/j.molmed.2009.02.003
46. Barletta KE, Cagnina RE, Wallace KL, Ramos SI, Mehrad B, Linden J. Leukocyte compartments in the mouse lung: distinguishing between marginated, interstitial, and alveolar cells in response to injury. J Immunol Methods (2012) 375:100-10. doi:10.1016/j.jim.2011.09.013
47. Streets AM, Zhang X, Cao C, Pang Y, Wu X, Xiong L, et al. Microfluidic single-cell whole-transcriptome sequencing. Proc Natl Acad Sci U S A (2014) 111:7048-53. doi:10.1073/pnas.1402030111
48. Treutlein B, Brownfield DG, Wu AR, Neff NF, Mantalas GL, Espinoza FH, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature (2014) 509:371-5. doi:10.1038/nature13173
49. Rackley CR, Stripp BR. Building and maintaining the epithelium of the lung. J Clin Invest (2012) 122:2724-30. doi:10.1172/JCI60519
50. Alanis DM, Chang DR, Akiyama H, Krasnow MA, Chen J. Two nested developmental waves demarcate a compartment boundary in the mouse lung. Nat Commun (2014) 5:3923. doi:10.1038/ncomms4923
51. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol (2002) 161:173-82. doi:10.1016/S0002-9440(10)64169-7
52. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol (2001) 24:671-81. doi:10.1165/ajrcmb.24.6.4498
53. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 121:823-35. doi:10.1016/j.cell.2005.03.032
54. Nolen-Walston RD, Kim CF, Mazan MR, Ingenito EP, Gruntman AM, Tsai L, et al. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol (2008) 294:L1158-65. doi:10.1152/ajplung.00298.2007
55. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ, et al. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A (2006) 103:9530-5. doi:10.1073/pnas.0510232103
56. Perl AK, Tichelaar JW, Whitsett JA. Conditional gene expression in the respiratory epithelium of the mouse. Transgenic Res (2002) 11:21-9. doi:10.1023/A:1013986627504
57. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A (2002) 99:10482-7. doi:10.1073/pnas.152238499
58. Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H, et al. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell (2009) 4:525-34. doi:10.1016/j.stem.2009.04.002
59. Zheng D, Limmon GV, Yin L, Leung NH, Yu H, Chow VT, et al. Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza. PLoS One (2012) 7:e48451. doi:10.1371/journal.pone.0048451
60. Zheng D, Limmon GV, Yin L, Leung NH, Yu H, Chow VT, et al. A cellular pathway involved in Clara cell to alveolar type II cell differentiation after severe lung injury. PLoS One (2013) 8:e71028. doi:10.1371/journal.pone.0071028
61. Adamson IY, Bowden DH, Wyatt JP. Oxygen poisoning in mice. Ultrastructural and surfactant studies during exposure and recovery. Arch Pathol (1970) 90:463-72
62. Bowden DH, Adamson IY, Wyatt JP. Reaction of the lung cells to a high concentration of oxygen. Arch Pathol (1968) 86:671-5
63. Kapanci Y, Weibel ER, Kaplan HP, Robinson FR. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies. Lab Invest (1969) 20:101-18
64. Adamson IY, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest (1974) 30:35-42
65. Evans MJ, Cabral LJ, Stephens RJ, Freeman G. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol (1975) 22:142-50. doi:10.1016/0014-4800(75)90059-3
66. Tryka AF, Witschi H, Gosslee DG, McArthur AH, Clapp NK. Patterns of cell proliferation during recovery from oxygen injury. Species differences. Am Rev Respir Dis (1986) 133:1055-9
67. Williams MC, Dobbs LG. Expression of cell-specific markers for alveolar epithelium in fetal rat lung. Am J Respir Cell Mol Biol (1990) 2:533-42. doi:10.1165/ajrcmb/2.6.533
68. Perl AK, Wert SE, Loudy DE, Shan Z, Blair PA, Whitsett JA. Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. Am J Respir Cell Mol Biol (2005) 33:455-62. doi:10.1165/rcmb.2005-0180OC
69. Gonzalez RF, Allen L, Dobbs LG. Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 297:L1045-55. doi:10.1152/ajplung.90389.2008
70. Garcia-Garcia ML, Gonzalez-Carrasco E, Quevedo S, Munoz C, Sanchez-Escudero V, Pozo F, et al. Clinical and virologic characteristics of early and moderate preterm infants readmitted with viral respiratory infections. Pediatr Infect Dis J (2015) 34(7):693-9. doi:10.1097/INF.0000000000000718
71. Olabarrieta I, Gonzalez-Carrasco E, Calvo C, Pozo F, Casas I, Garcia-Garcia ML. Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life. Allergol Immunopathol (Madr) (2014). doi:10.1016/j.aller.2014.06.006
72. Carbonell-Estrany X, Perez-Yarza EG, Garcia LS, Guzman Cabanas JM, Boria EV, Atienza BB, et al. Long-term burden and respiratory effects of respiratory syncytial virus hospitalization in preterm infants-the SPRING study. PLoS One (2015) 10:e0125422. doi:10.1371/journal.pone.0125422
73. Miller EK, Bugna J, Libster R, Shepherd BE, Scalzo PM, Acosta PL, et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics (2012) 129:e60-7. doi:10.1542/peds.2011-0583
74. van Piggelen RO, Van Loon AM, Krediet TG, Verboon-Maciolek MA. Human rhinovirus causes severe infection in preterm infants. Pediatr Infect Dis J (2010) 29:364-5. doi:10.1097/INF.0b013e3181c6e60f
75. Drysdale SB, Alcazar-Paris M, Wilson T, Smith M, Zuckerman M, Broughton S, et al. Rhinovirus infection and healthcare utilisation in prematurely born infants. Eur Respir J (2013) 42:1029-36. doi:10.1183/09031936.00109012
76. Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Lauinger IL, et al. Respiratory outcome of prematurely born infants following human rhinovirus A and C infections. Eur J Pediatr (2014) 173:913-9. doi:10.1007/s00431-014-2262-1
77. Jackson DJ, Hartert TV, Martinez FD, Weiss ST, Fahy JV. Asthma: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc (2014) 11(Suppl 3):S139-45. doi:10.1513/AnnalsATS.201312-448LD
78. American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics (2014) 134:415-20. doi:10.1542/peds.2014-1665
79. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics (2004) 113:1758-64. doi:10.1542/peds.113.6.1758
80. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J (1997) 16:1065-8. doi:10.1097/00006454-199711000-00012
81. Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncytial virus-a comprehensive review. Clin Rev Allergy Immunol (2013) 45:331-79. doi:10.1007/s12016-013-8368-9
82. Bem RA, Domachowske JB, Rosenberg HF. Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol (2011) 301:L148-56. doi:10.1152/ajplung.00065.2011
83. Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe (2010) 7:440-51. doi:10.1016/j.chom.2010.05.009
84. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A (2010) 107:11531-6. doi:10.1073/pnas.0914994107
85. Nogales A, Baker SF, Martinez-Sobrido L. Replication-competent influenza A viruses expressing a red fluorescent protein. Virology (2015) 476:206-16. doi:10.1016/j.virol.2014.12.006
86. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res (1993) 29:155-65. doi:10.1016/0168-1702(93)90056-S
87. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature (2006) 440:435-6. doi:10.1038/440435a
88. van Riel D, Den Bakker MA, Leijten LM, Chutinimitkul S, Munster VJ, De Wit E, et al. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol (2010) 176:1614-8. doi:10.2353/ajpath.2010.090949
89. van Riel D, Munster VJ, De Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 171:1215-23. doi:10.2353/ajpath.2007.070248
90. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med (2007) 13:147-9. doi:10.1038/nm1529
91. Thompson CI, Barclay WS, Zambon MC, Pickles RJ. Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol (2006) 80:8060-8. doi:10.1128/JVI.00384-06
92. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A (2004) 101:4620-4. doi:10.1073/pnas.0308001101
93. Wang J, Nikrad MP, Phang T, Gao B, Alford T, Ito Y, et al. Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am J Respir Cell Mol Biol (2011) 45:582-91. doi:10.1165/rcmb.2010-0108OC
94. Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, Mu D, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell (2011) 147:525-38. doi:10.1016/j.cell.2011.10.001
95. Zuo W, Zhang T, Wu DZ, Guan SP, Liew AA, Yamamoto Y, et al. p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. Nature (2015) 517:616-20. doi:10.1038/nature13903
96. Smith LJ, McKay KO, Van Asperen PP, Selvadurai H, Fitzgerald DA. Normal development of the lung and premature birth. Paediatr Respir Rev (2010) 11:135-42. doi:10.1016/j.prrv.2009.12.006
97. Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol (2015) 16:27-35. doi:10.1038/ni.3045
98. Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest (2012) 122:2741-8. doi:10.1172/JCI60325
99. Felton JM, Lucas CD, Rossi AG, Dransfield I. Eosinophils in the lung-modulating apoptosis and efferocytosis in airway inflammation. Front Immunol (2014) 5:302. doi:10.3389/fimmu.2014.00302
100. Bhattacharya S, Go D, Krenitsky DL, Huyck HL, Solleti SK, Lunger VA, et al. Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med (2012) 186:349-58. doi:10.1164/rccm.201203-0406OC
101. Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med (2007) 175:978-85. doi:10.1164/rccm.200611-1660PP
102. Yee M, Buczynski BW, O'Reilly MA. Neonatal hyperoxia stimulates the expansion of alveolar epithelial type II cells. Am J Respir Cell Mol Biol (2014) 50:757-66. doi:10.1165/rcmb.2013-0207OC
103. Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath-Morrow SA, et al. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol (2006) 291:L1101-11. doi:10.1152/ajplung.00126.2006
104. O'Reilly MA, Yee M, Buczynski BW, Vitiello PF, Keng PC, Welle SL, et al. Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. Am J Pathol (2012) 181:441-51. doi:10.1016/j.ajpath.2012.05.005
105. Buczynski BW, Yee M, Paige Lawrence B, O'Reilly MA. Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice. Am J Physiol Lung Cell Mol Physiol (2012) 302:L1078-87. doi:10.1152/ajplung.00026.2012
106. Giannandrea M, Yee M, O'Reilly MA, Lawrence BP. Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation. Clin Vaccine Immunol (2012) 19:1432-41. doi:10.1128/CVI.00265-12
107. Yee M, Chess PR, McGrath-Morrow SA, Wang Z, Gelein R, Zhou R, et al. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol (2009) 297:L641-9. doi:10.1152/ajplung.00023.2009
108. Yee M, Buczynski BW, Lawrence BP, O'Reilly MA. Neonatal hyperoxia increases sensitivity of adult mice to bleomycin-induced lung fibrosis. Am J Respir Cell Mol Biol (2013) 48:258-66. doi:10.1165/rcmb.2012-0238OC
109. Kohlmeier JE, Woodland DL. Immunity to respiratory viruses. Annu Rev Immunol (2009) 27:61-82. doi:10.1146/annurev.immunol.021908.132625
110. O'Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med (2008) 177:1103-10. doi:10.1164/rccm.200712-1839OC
111. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 29:313-26. doi:10.1089/jir.2008.0027
112. Dessing MC, Van Der Sluijs KF, Florquin S, Van Der Poll T. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol (2007) 125:328-36. doi:10.1016/j.clim.2007.08.001
113. Hartl D, Griese M, Nicolai T, Zissel G, Prell C, Reinhardt D, et al. A role for MCP-1/CCR2 in interstitial lung disease in children. Respir Res (2005) 6:93. doi:10.1186/1465-9921-6-32
114. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J (1999) 14:376-82. doi:10.1183/09031936.99.14237699
115. Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol (2014) 100:189-201. doi:10.1002/bdra.23220
116. Knight DA, Ernst M, Anderson GP, Moodley YP, Mutsaers SE. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol Ther (2003) 99:327-38. doi:10.1016/S0163-7258(03)00095-0
117. Xu Y, Tian Z, Xie P. Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice. Mol Med Rep (2014) 10:1786-92. doi:10.3892/mmr.2014.2394
118. Garcia CC, Weston-Davies W, Russo RC, Tavares LP, Rachid MA, Alves-Filho JC, et al. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS One (2013) 8:e64443. doi:10.1371/journal.pone.0064443
119. Gu H, Mickler EA, Cummings OW, Sandusky GE, Weber DJ, Gracon A, et al. Crosstalk between TGF-beta1 and complement activation augments epithelial injury in pulmonary fibrosis. FASEB J (2014) 28:4223-34. doi:10.1096/fj.13-247650
120. Bhandari V. Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets. Front Pediatr (2014) 2:76. doi:10.3389/fped.2014.00076
121. Nyunoya T, Powers LS, Yarovinsky TO, Butler NS, Monick MM, Hunninghake GW. Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. J Biol Chem (2003) 278:36099-106. doi:10.1074/jbc.M304370200
122. Wang M, Gorasiya S, Antoine DJ, Sitapara RA, Wu W, Sharma L, et al. The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-kappaB-mediated release of high-mobility group box-1. Am J Respir Cell Mol Biol (2015) 52:171-82. doi:10.1165/rcmb.2013-0544OC
123. Sturrock A, Vollbrecht T, Mir-Kasimov M, McManus M, Wilcoxen SE, Paine R III. Mechanisms of suppression of alveolar epithelial cell GM-CSF expression in the setting of hyperoxic stress. Am J Physiol Lung Cell Mol Physiol (2010) 298:L446-53. doi:10.1152/ajplung.00161.2009
124. Sturrock A, Baker JA, Mir-Kasimov M, Paine R III. Contrasting effects of hyperoxia on GM-CSF gene transcription in alveolar epithelial cells and T cells. Physiol Rep (2015) 3(3):e12324. doi:10.14814/phy2.12324
125. Jones CV, Williams TM, Walker KA, Dickinson H, Sakkal S, Rumballe BA, et al. M2 macrophage polarisation is associated with alveolar formation during postnatal lung development. Respir Res (2013) 14:41. doi:10.1186/1465-9921-14-41
126. Syed MA, Bhandari V. Hyperoxia exacerbates postnatal inflammation-induced lung injury in neonatal BRP-39 null mutant mice promoting the M1 macrophage phenotype. Mediators Inflamm (2013) 2013:457189. doi:10.1155/2013/457189
127. Sureshbabu A, Syed MA, Boddupalli C, Dhodapkar MV, Homer RJ, Minoo P, et al. Conditional overexpression of TGFss1 promotes pulmonary inflammation, apoptosis and mortality via TGFssR2 in the developing mouse lung. Respir Res (2015) 16:4. doi:10.1186/s12931-014-0162-6
128. Duan W, Croft M. Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells. Ann Am Thorac Soc (2014) 11(Suppl 5):S306-13. doi:10.1513/AnnalsATS.201401-028AW
129. Costa A, Sarmento B, Seabra V. Targeted drug delivery systems for lung macrophages. Curr Drug Targets (2014). doi:10.2174/1389450115666141114152713
130. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med (2011) 17:293-307. doi:10.2119/molmed.2010.00138
131. Nagato AC, Bezerra FS, Lanzetti M, Lopes AA, Silva MA, Porto LC, et al. Time course of inflammation, oxidative stress and tissue damage induced by hyperoxia in mouse lungs. Int J Exp Pathol (2012) 93:269-78. doi:10.1111/j.1365-2613.2012.00823.x
132. Min JH, Codipilly CN, Nasim S, Miller EJ, Ahmed MN. Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression. Respir Res (2012) 13:58. doi:10.1186/1465-9921-13-58
133. Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Buhrer C, et al. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J (2013) 41:966-73. doi:10.1183/09031936.00012412
134. Benipal B, Feinstein SI, Chatterjee S, Dodia C, Fisher AB. Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia. Redox Biol (2015) 4:321-7. doi:10.1016/j.redox.2015.01.011
135. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 13:159-75. doi:10.1038/nri3399
136. Juul SE, Haynes JW, McPherson RJ. Evaluation of neutropenia and neutrophilia in hospitalized preterm infants. J Perinatol (2004) 24:150-7. doi:10.1038/sj.jp.7211057
137. Nittala S, Subbarao GC, Maheshwari A. Evaluation of neutropenia and neutrophilia in preterm infants. J Matern Fetal Neonatal Med (2012) 25:100-3. doi:10.3109/14767058.2012.715468
138. Del Vecchio A, Christensen RD. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended? Early Hum Dev (2012) 88(Suppl 2):S19-24. doi:10.1016/S0378-3782(12)70007-5
139. Munshi UK, Niu JO, Siddiq MM, Parton LA. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol (1997) 24:331-6. doi:10.1002/(SICI)1099-0496(199711)24:5<331::AID-PPUL5>3.0.CO;2-L
140. Ballabh P, Simm M, Kumari J, Krauss AN, Jain A, Califano C, et al. Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids. Arch Dis Child Fetal Neonatal Ed (2004) 89:F76-83. doi:10.1136/fn.89.1.F76
141. Inoue H, Ohga S, Kusuda T, Kitajima J, Kinjo T, Ochiai M, et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants. Early Hum Dev (2013) 89:425-9. doi:10.1016/j.earlhumdev.2012.12.011
142. Teig N, Allali M, Rieger C, Hamelmann E. Inflammatory markers in induced sputum of school children born before 32 completed weeks of gestation. J Pediatr (2012) 161:1085-90. doi:10.1016/j.jpeds.2012.06.007
143. Misra RS. A review of the CD4+ T cell contribution to lung infection, inflammation and repair with a focus on wheeze and asthma in the pediatric population. EC Microbiol (2014) 1(1):4-14
144. Vroman H, Van Den Blink B, Kool M. Mode of dendritic cell activation: the decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity? Immunobiology (2015) 220:254-61. doi:10.1016/j.imbio.2014.09.016
145. Perez GF, Pancham K, Huseni S, Jain A, Rodriguez-Martinez CE, Preciado D, et al. Rhinovirus-induced airway cytokines and respiratory morbidity in severely premature children. Pediatr Allergy Immunol (2015) 26:145-52. doi:10.1111/pai.12346
146. Tan DB, Fernandez S, Price P, French MA, Thompson PJ, Moodley YP. Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD). Immunobiology (2014) 219:975-9. doi:10.1016/j.imbio.2014.07.005
147. Zhang X, Mozeleski B, Lemoine S, Deriaud E, Lim A, Zhivaki D, et al. CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus. Sci Transl Med (2014) 6:238ra72. doi:10.1126/scitranslmed.3008748
148. Misra RS, Shah S, Fowell DJ, Wang H, Scheible K, Misra SK, et al. Preterm cord blood CD4+ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4+ T cells in bronchopulmonary dysplasia. Hum Immunol (2015) 76(5):329-38. doi:10.1016/j.humimm.2015.03.007
149. Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD-implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis (2014) 9:1207-24. doi:10.2147/COPD.S51226
150. Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep (2013) 18:88-94. doi:10.1179/1351000213Y.0000000044
151. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med (2010) 48:749-62. doi:10.1016/j.freeradbiomed.2009.12.022
152. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol (2014) 24:R453-62. doi:10.1016/j.cub.2014.03.034
153. Secchi C, Carta M, Crescio C, Spano A, Arras M, Caocci G, et al. T cell tyrosine phosphorylation response to transient redox stress. Cell Signal (2015) 27:777-88. doi:10.1016/j.cellsig.2014.12.014
154. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med (2011) 208:1339-50. doi:10.1084/jem.20110551
155. Kim SR, Kim DI, Kim SH, Lee H, Lee KS, Cho SH, et al. NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation. Cell Death Dis (2014) 5:e1498. doi:10.1038/cddis.2014.460
156. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol (2013) 13:145-9. doi:10.1038/nri3365
157. Sanos SL, Diefenbach A. Innate lymphoid cells: from border protection to the initiation of inflammatory diseases. Immunol Cell Biol (2013) 91:215-24. doi:10.1038/icb.2013.3
158. Seillet C, Rankin LC, Groom JR, Mielke LA, Tellier J, Chopin M, et al. Nfil3 is required for the development of all innate lymphoid cell subsets. J Exp Med (2014) 211:1733-40. doi:10.1084/jem.20140145
159. Roediger B, Weninger W. Group 2 innate lymphoid cells in the regulation of immune responses. Adv Immunol (2015) 125:111-54. doi:10.1016/bs.ai.2014.09.004
160. DeKruyff RH, Yu S, Kim HY, Umetsu DT. Innate immunity in the lung regulates the development of asthma. Immunol Rev (2014) 260:235-48. doi:10.1111/imr.12187
161. Chapman AM, Malkin DJ, Camacho J, Schiestl RH. IL-13 overexpression in mouse lungs triggers systemic genotoxicity in peripheral blood. Mutat Res (2014) 769:100-7. doi:10.1016/j.mrfmmm.2014.06.007
162. Ba X, Aguilera-Aguirre L, Sur S, Boldogh I. 8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair: role in asthma pathogenesis. Curr Opin Allergy Clin Immunol (2015) 15:89-97. doi:10.1097/ACI.0000000000000135
163. Entezari M, Javdan M, Antoine DJ, Morrow DM, Sitapara RA, Patel V, et al. Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biol (2014) 2:314-22. doi:10.1016/j.redox.2014.01.013
164. Bigham A, Bauchet M, Pinto D, Mao X, Akey JM, Mei R, et al. Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet (2010) 6:e1001116. doi:10.1371/journal.pgen.1001116
165. Yi X, Liang Y, Huerta-Sanchez E, Jin X, Cuo ZX, Pool JE, et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 329:75-8. doi:10.1126/science.1190371
166. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, Witherspoon DJ, et al. Genetic evidence for high-altitude adaptation in Tibet. Science (2010) 329:72-5. doi:10.1126/science.1189406
167. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, Knight J, et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A (2010) 107:11459-64. doi:10.1073/pnas.1002443107
168. Alkorta-Aranburu G, Beall CM, Witonsky DB, Gebremedhin A, Pritchard JK, Di Rienzo A. The genetic architecture of adaptations to high altitude in Ethiopia. PLoS Genet (2012) 8:e1003110. doi:10.1371/journal.pgen.1003110
169. Frisancho AR. Developmental functional adaptation to high altitude: review. Am J Hum Biol (2013) 25:151-68. doi:10.1002/ajhb.22367
170. Choudhuri JA, Ogden LG, Ruttenber AJ, Thomas DS, Todd JK, Simoes EA. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics (2006) 117:349-56. doi:10.1542/peds.2004-2795
171. Yan X. Pro: all dwellers at high altitude are persons of impaired physical and mental powers. High Alt Med Biol (2013) 14:208-11. doi:10.1089/ham.2013.1026
172. Voss JD, Allison DB, Webber BJ, Otto JL, Clark LL. Lower obesity rate during residence at high altitude among a military population with frequent migration: a quasi experimental model for investigating spatial causation. PLoS One (2014) 9:e93493. doi:10.1371/journal.pone.0093493
173. Soria R, Julian CG, Vargas E, Moore LG, Giussani DA. Graduated effects of high-altitude hypoxia and highland ancestry on birth size. Pediatr Res (2013) 74:633-8. doi:10.1038/pr.2013.150